Results

Total Results: over 10,000 records

Showing results for "stage".

361. Module 5: How To Measure Pressure Injury Rates and Prevention Practices (doc file)
     preventiveservices.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/pressure_ulcer_prevention/module5/module5_pu_measurement.docx
     January 01, 2016 - Stage 1 may be difficult to detect in individuals with dark skin tones. … With Stage 2: · The wound bed is viable, pink or red, and moist. … Slide 10 SAY: Stage 3 presents as a full-thickness tissue loss. … If slough or eschar is removed, a Stage 3 or Stage 4 pressure injury will be revealed. … Root cause analysis is conducted for each >Stage 2 pressure injury.

362. Module 5: How To Measure Pressure Injury Rates and Prevention Practices (doc file)
     ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/pressure_ulcer_prevention/module5/module5_pu_measurement.docx
     January 01, 2016 - Stage 1 may be difficult to detect in individuals with dark skin tones. … With Stage 2: · The wound bed is viable, pink or red, and moist. … Slide 10 SAY: Stage 3 presents as a full-thickness tissue loss. … If slough or eschar is removed, a Stage 3 or Stage 4 pressure injury will be revealed. … Root cause analysis is conducted for each >Stage 2 pressure injury.

363. Colorectal-Cancer-Protocol_130520 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
     May 20, 2013 - However, stage is the key determinant of the management strategy. … that is compared against the stage established by the reference standard. … Stage reclassification or clinical decision impact. … Stage reclassification. … The change in stage of the cancer after imaging, compared with the stage determined based on information

364. Colorectal-Cancer-Protocol_130520 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
     May 20, 2013 - However, stage is the key determinant of the management strategy. … that is compared against the stage established by the reference standard. … Stage reclassification or clinical decision impact. … Stage reclassification. … The change in stage of the cancer after imaging, compared with the stage determined based on information

365. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - • Stage 2: Kidney damage with GFR 60–89 mL/min/ 1.73 m2. … 1 or 2, nearly another half are stage 3, fewer than 4 percent are stage 4, and fewer than 2 percent … are stage 5 and receive dialysis. … Screening for Early-Stage CKD The rationale for considering screening for early- stage CKD includes … 1–3 and stage 4–5 CKD, and did not separate results by CKD stage or severity

366. Kidney-Disease-Medicine Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/kidney-disease-medicine_executive.pdf
     January 01, 2012 - • Stage 2: Kidney damage with GFR 60–89 mL/min/ 1.73 m2. … 1 or 2, nearly another half are stage 3, fewer than 4 percent are stage 4, and fewer than 2 percent … are stage 5 and receive dialysis. … Screening for Early-Stage CKD The rationale for considering screening for early- stage CKD includes … 1–3 and stage 4–5 CKD, and did not separate results by CKD stage or severity

367. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
     December 08, 2014 - , the Veterans Administration Lung Study Group (VALSG) system,5 classifies SCLC as either “limited stage … ” or “extensive stage” disease with the following definitions: o Limited stage disease (LD): Cancer … o Extensive stage disease (ED): Cancer that cannot be classified as limited stage, such as when there … This information is used to assign a stage between I and IV. … A higher stage represents a more extensive spread of the cancer.

368. Protocol: Imaging for Pretreatment Staging of Small Cell Lung Cancer (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/lung-cancer-staging_research-protocol.pdf
     December 08, 2014 - , the Veterans Administration Lung Study Group (VALSG) system,5 classifies SCLC as either “limited stage … ” or “extensive stage” disease with the following definitions: o Limited stage disease (LD): Cancer … o Extensive stage disease (ED): Cancer that cannot be classified as limited stage, such as when there … This information is used to assign a stage between I and IV. … A higher stage represents a more extensive spread of the cancer.

369. Imaging for the Pretreatment Staging of Small Cell Lung Cancer | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/lung-cancer-staging/research
     December 01, 2019 - Skip to main content An official website of the Department of Health & Human Services Careers Contact Us Español FAQs Effective Health Care Program Powered by the Evidence-based Practice Centers …

370. PowerPoint Presentation
     cds.ahrq.gov/sites/default/files/cds/artifact/106/AMIA_presentation.pptx
     January 01, 2012 - onto building decision support and putting it into practice 5 5 How We Designed Healthy Weight Stage … 1: Freehand mockup Stage 2 Wireframe mockup Stage 3 Interactive module Stage 4 User testing, feedback … Stage 5 Redesign, Enhance, Evaluate 6 Stage 1 Quick, easy, low overhead, adaptable Stage 2 Layout … , spacing, internal workflow (white box testing) Stage 3 Interactivity, data handling, processing speed

371. NHQDR Web Site - National Prevention Benchmark Details
     nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Type_of_Care/Prevention
     February 19, 2021 - ever received pneumococcal vaccination 69.0 78.7 12.3% Breast cancer diagnosed at advanced stage … (regional, distant stage, or local stage with tumor greater than 2 cm) per 100,000 women age 40 and … over 84.5 74.2 13.8% Colorectal cancer diagnosed at advanced stage (tumors diagnosed at regional … or distant stage) per 100,000 population age 50 and over 63.8 48.9 30.4% Cervical cancer … diagnosed at advanced stage (all invasive tumors) per 100,000 women age 20 and over 10.5 7.7 36.0%

372. Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening
     July 30, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection … Stage II: 0.3% ( n = 4) vs. 0.2% (n = 2) Stage IIIA: 0.6% ( n = 7) vs. 0.3% ( n = 4) Stage … : 31/35     Stage IA: 20/16     Stage IB: 2/1     Stage IIA: 4/4     Stage IIB: 0 … /2     Stage IIIA: 2/4     Stage IIIB: 0/2     Stage IV: 1/0     Unknown: 0/2      … I: 58%   Stage II: 17%   Stage III: 30%   Stage IV: 7%   Additional procedures

373. Archived: Evidence Summary: Lung Cancer: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary4/lung-cancer-screening-december-2013
     July 30, 2013 - Because early-stage lung cancer is associated with lower mortality than late-stage disease, early detection … NR Stage IV: 17% vs. 15% vs. … : 31/35     Stage IA: 20/16     Stage IB: 2/1     Stage IIA: 4/4     Stage IIB: 0 … /2     Stage IIIA: 2/4     Stage IIIB: 0/2     Stage IV: 1/0     Unknown: 0/2      … I: 58%   Stage II: 17%   Stage III: 30%   Stage IV: 7%   Additional procedures

374. Healthcare Cost and Utilization Project (HCUP) NIS Notes
     hcup-us.ahrq.gov/db/vars/ds_stage1/nisnote.jsp
     September 01, 2008 - TOOLS NIS Description of Data Elements   DS_Stage1 - Disease Staging: Stage … This severity measure includes the disease category and stage for the principal diagnosis and predictive … Uniform Values Variable Description Value Value Description DS_Stage1 Disease Staging: Stage … of Principal Disease Category n.nn Principal Stage .

375. Healthcare Cost and Utilization Project (HCUP) KID Notes
     hcup-us.ahrq.gov/db/vars/ds_stage1/kidnote.jsp
     September 01, 2008 - TOOLS KID Description of Data Elements   DS_Stage1 - Disease Staging: Stage … This severity measure includes the disease category and stage for the principal diagnosis and predictive … Uniform Values Variable Description Value Value Description DS_Stage1 Disease Staging: Stage … of Principal Disease Category n.nn Principal Stage .

376. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/renal-cancer/clinician
     July 18, 2017 - for localized renal cell carcinoma range from greater than 85 percent to 95 percent, depending on the stage … Thermal ablation and active surveillance are considered options for patients with clinical stage T1a … Radical nephrectomy is recommended as the standard of care for most patients with clinical stage T2 tumors … CKD stage ≥3: RR 0.88 (0.60 to 1.30) CKD stage ≥3b: RR 2.78 (0.47 to 16.54) CKD stage ≥4: RR 0.76 … CKD stage ≥3: RR 0.39 (0.30 to 0.51) CKD stage ≥3b: RR 0.37 (0.26 to 0.53) CKD stage ≥4: RR 0.76

377. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
     July 01, 2017 - localized renal cell carcinoma range from greater than 85 percent to 95 percent, depending on the stage … Thermal ablation and active surveillance are considered options for patients with clinical stage T1a … Radical nephrectomy is recommended as the standard of care for most patients with clinical stage T2 … CKD stage ≥3: RR 0.88 (0.60 to 1.30) CKD stage ≥3b: RR 2.78 (0.47 to 16.54) CKD stage ≥4: RR 0.76 ( … CKD stage ≥3: RR 0.39 (0.30 to 0.51) CKD stage ≥3b: RR 0.37 (0.26 to 0.53) CKD stage ≥4: RR 0.76 (0.54

378. Management of Renal Masses and Localized Renal Cell Carcinoma: Current State of the Evidence (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/renal-cancer_clinician.pdf
     July 01, 2017 - localized renal cell carcinoma range from greater than 85 percent to 95 percent, depending on the stage … Thermal ablation and active surveillance are considered options for patients with clinical stage T1a … Radical nephrectomy is recommended as the standard of care for most patients with clinical stage T2 … CKD stage ≥3: RR 0.88 (0.60 to 1.30) CKD stage ≥3b: RR 2.78 (0.47 to 16.54) CKD stage ≥4: RR 0.76 ( … CKD stage ≥3: RR 0.39 (0.30 to 0.51) CKD stage ≥3b: RR 0.37 (0.26 to 0.53) CKD stage ≥4: RR 0.76 (0.54

379. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
     February 01, 2011 - to 8 percent among beneficiaries in Stage I; from 13 percent to 7 percent in Stage II; from 23 percent … Stage II: The inclusion criteria for the stage II population included beneficiaries: (1) enrolled in … Stage IV: The inclusion criteria for the stage IV population included beneficia- ries: (1) enrolled in … Stage V: The inclusion criteria for the stage V population included beneficiaries: (1) enrolled in Part … Stage VI: The inclusion criteria for the stage VI population included beneficia- ries: (1) enrolled in

380. Erythropoiesis-Stimulating-Agents-Utilization Research (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/erythropoiesis-stimulating-agents-utilization_research.pdf
     February 01, 2011 - to 8 percent among beneficiaries in Stage I; from 13 percent to 7 percent in Stage II; from 23 percent … Stage II: The inclusion criteria for the stage II population included beneficiaries: (1) enrolled in … Stage IV: The inclusion criteria for the stage IV population included beneficia- ries: (1) enrolled in … Stage V: The inclusion criteria for the stage V population included beneficiaries: (1) enrolled in Part … Stage VI: The inclusion criteria for the stage VI population included beneficia- ries: (1) enrolled in